A detailed history of High Tower Advisors, LLC transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 57,413 shares of RMTI stock, worth $135,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,413
Previous 32,698 75.59%
Holding current value
$135,494
Previous $57,000 298.25%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.67 - $4.4 $41,274 - $108,746
24,715 Added 75.59%
57,413 $227,000
Q4 2023

Feb 12, 2024

SELL
$1.58 - $2.44 $34 - $53
-22 Reduced 0.07%
32,698 $61,000
Q3 2023

Nov 08, 2023

BUY
$1.83 - $6.19 $59,877 - $202,536
32,720 New
32,720 $68,000

Others Institutions Holding RMTI

About ROCKWELL MEDICAL, INC.


  • Ticker RMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,675,200
  • Market Cap $25.2M
  • Description
  • Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...
More about RMTI
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.